| Product Code: ETC6015134 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Afghanistan Pharmacovigilance Market Overview |
3.1 Afghanistan Country Macro Economic Indicators |
3.2 Afghanistan Pharmacovigilance Market Revenues & Volume, 2021 & 2031F |
3.3 Afghanistan Pharmacovigilance Market - Industry Life Cycle |
3.4 Afghanistan Pharmacovigilance Market - Porter's Five Forces |
3.5 Afghanistan Pharmacovigilance Market Revenues & Volume Share, By Clinical Trial Phase, 2021 & 2031F |
3.6 Afghanistan Pharmacovigilance Market Revenues & Volume Share, By Service Provider, 2021 & 2031F |
3.7 Afghanistan Pharmacovigilance Market Revenues & Volume Share, By Type of Reporting, 2021 & 2031F |
3.8 Afghanistan Pharmacovigilance Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Afghanistan Pharmacovigilance Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing focus on patient safety and drug efficacy in Afghanistan |
4.2.2 Growing awareness about adverse drug reactions among healthcare professionals |
4.2.3 Implementation of regulations and guidelines to strengthen pharmacovigilance practices in the country |
4.3 Market Restraints |
4.3.1 Limited resources and infrastructure for pharmacovigilance activities in Afghanistan |
4.3.2 Lack of trained personnel in pharmacovigilance |
4.3.3 Underreporting and inadequate monitoring of adverse drug reactions |
5 Afghanistan Pharmacovigilance Market Trends |
6 Afghanistan Pharmacovigilance Market, By Types |
6.1 Afghanistan Pharmacovigilance Market, By Clinical Trial Phase |
6.1.1 Overview and Analysis |
6.1.2 Afghanistan Pharmacovigilance Market Revenues & Volume, By Clinical Trial Phase, 2021- 2031F |
6.1.3 Afghanistan Pharmacovigilance Market Revenues & Volume, By Preclinical, 2021- 2031F |
6.1.4 Afghanistan Pharmacovigilance Market Revenues & Volume, By Phase I, 2021- 2031F |
6.1.5 Afghanistan Pharmacovigilance Market Revenues & Volume, By Phase II, 2021- 2031F |
6.1.6 Afghanistan Pharmacovigilance Market Revenues & Volume, By Phase III, 2021- 2031F |
6.1.7 Afghanistan Pharmacovigilance Market Revenues & Volume, By Phase IV, 2021- 2031F |
6.2 Afghanistan Pharmacovigilance Market, By Service Provider |
6.2.1 Overview and Analysis |
6.2.2 Afghanistan Pharmacovigilance Market Revenues & Volume, By In-house, 2021- 2031F |
6.2.3 Afghanistan Pharmacovigilance Market Revenues & Volume, By Contract Outsourcing, 2021- 2031F |
6.3 Afghanistan Pharmacovigilance Market, By Type of Reporting |
6.3.1 Overview and Analysis |
6.3.2 Afghanistan Pharmacovigilance Market Revenues & Volume, By Spontaneous Reporting, 2021- 2031F |
6.3.3 Afghanistan Pharmacovigilance Market Revenues & Volume, By Intensified ADR Reporting, 2021- 2031F |
6.3.4 Afghanistan Pharmacovigilance Market Revenues & Volume, By Targeted Spontaneous Reporting, 2021- 2031F |
6.3.5 Afghanistan Pharmacovigilance Market Revenues & Volume, By Cohort Event Monitoring, 2021- 2031F |
6.3.6 Afghanistan Pharmacovigilance Market Revenues & Volume, By EHR Mining, 2021- 2031F |
6.4 Afghanistan Pharmacovigilance Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Afghanistan Pharmacovigilance Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Afghanistan Pharmacovigilance Market Revenues & Volume, By Pharmaceutical Companies, 2021- 2031F |
6.4.4 Afghanistan Pharmacovigilance Market Revenues & Volume, By Other End Users, 2021- 2031F |
7 Afghanistan Pharmacovigilance Market Import-Export Trade Statistics |
7.1 Afghanistan Pharmacovigilance Market Export to Major Countries |
7.2 Afghanistan Pharmacovigilance Market Imports from Major Countries |
8 Afghanistan Pharmacovigilance Market Key Performance Indicators |
8.1 Number of adverse drug reaction reports submitted annually |
8.2 Percentage increase in healthcare professionals trained in pharmacovigilance |
8.3 Compliance rate with pharmacovigilance regulations and guidelines |
8.4 Number of pharmacovigilance awareness campaigns conducted |
8.5 Efficiency of communication channels for reporting adverse drug reactions |
9 Afghanistan Pharmacovigilance Market - Opportunity Assessment |
9.1 Afghanistan Pharmacovigilance Market Opportunity Assessment, By Clinical Trial Phase, 2021 & 2031F |
9.2 Afghanistan Pharmacovigilance Market Opportunity Assessment, By Service Provider, 2021 & 2031F |
9.3 Afghanistan Pharmacovigilance Market Opportunity Assessment, By Type of Reporting, 2021 & 2031F |
9.4 Afghanistan Pharmacovigilance Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Afghanistan Pharmacovigilance Market - Competitive Landscape |
10.1 Afghanistan Pharmacovigilance Market Revenue Share, By Companies, 2024 |
10.2 Afghanistan Pharmacovigilance Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here